Claudia Solari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claudia Solari has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Alejandra Guberman
Laboratorio de Regulación Génica en Células Madre, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
5 shared publications - Santiago Gabriel Miriuka
Laboratorio de Investigación Aplicada a Neurociencias (LIAN), Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Instituto de Neurociencias (INEU), CONICET, Buenos Aires, Argentina
5 shared publications - Ariel Waisman
FLENI
4 shared publications - Gustavo Sevlever
INEU-CONICET, FLENI, Buenos Aires, Argentina
4 shared publications - Lino Barañao
Departamento de Química Biológica/Laboratorio de Regulación Génica en Células Madre, Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Buenos Aires, Argentina
4 shared publications - Carlos Luzzani
Laboratorio de Regulación de Expresión Génica en el Crecimiento, Supervivencia y Diferenciación Celular, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina
2 shared publications
Latest Publications
- 1 December 2018
- Published by Elsevier in Mechanisms of Development
- Vol. 154, 116-121
Superoxide dismutase 1 expression is modulated by the core pluripotency transcription factors Oct4, Sox2 and Nanog in embryonic stem cells
- 1 December 2018
- Published by Elsevier in Mechanisms of Development
- Vol. 154, 116-121
Superoxide dismutase 1 expression is modulated by the core pluripotency transcription factors Oct4, Sox2 and Nanog in embryonic stem cells
- 1 April 2016
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 473 (1) , 194-199
Protein arginine Methyltransferase 8 gene is expressed in pluripotent stem cells and its expression is modulated by the transcription factor Sox2
- 1 April 2016
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 473 (1) , 194-199
Protein arginine Methyltransferase 8 gene is expressed in pluripotent stem cells and its expression is modulated by the transcription factor Sox2
- Open Access
- 12 January 2015
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 6 (1) , 6
A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement
Introduction: Mesenchymal stem cells (MSCs) are a promising source of cells for regenerative therapies. Although they can be isolated easily from several tissues, cell expansion is limited since their properties are lost with successive passages. Hence, pluripotent derived MSCs (PD-MSCs) arise as a suitable alternative for MSC production. Nevertheless, at present, PD-MSC derivation protocols are either expensive or not suitable for clinical purposes. Methods: In this work we present a therapy-grade, inexpensive and simple protocol to derive MSCs from pluripotent stem cells (PSCs) based on the use of platelet lysate (PL) as medium supplement. Results: We showed that the PD-MSCPL expressed multiple MSC markers, including CD90, CD73, CD105, CD166, and CD271, among others. These cells also show multilineage differentiation ability and immunomodulatory effects on pre-stimulated lymphocytes. Thorough characterization of these cells showed that a PD-MSCPL resembles an umbilical cord (UC) MSC and differs from a PSC in surface marker and extracellular matrix proteins and integrin expression. Moreover, the OCT-4 promoter is re-methylated with mesenchymal differentiation comparable with the methylation levels of UC-MSCs and fibroblasts. Lastly, the use of PL-supplemented medium generates significantly more MSCs than the use of fetal bovine serum. Conclusions: This protocol can be used to generate a large amount of PD-MSCs with low cost and is compatible with clinical therapies.
- 12 January 2015
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 6 (1) , 6
Open AccessA therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement
Introduction: Mesenchymal stem cells (MSCs) are a promising source of cells for regenerative therapies. Although they can be isolated easily from several tissues, cell expansion is limited since their properties are lost with successive passages. Hence, pluripotent derived MSCs (PD-MSCs) arise as a suitable alternative for MSC production. Nevertheless, at present, PD-MSC derivation protocols are either expensive or not suitable for clinical purposes. Methods: In this work we present a therapy-grade, inexpensive and simple protocol to derive MSCs from pluripotent stem cells (PSCs) based on the use of platelet lysate (PL) as medium supplement. Results: We showed that the PD-MSCPL expressed multiple MSC markers, including CD90, CD73, CD105, CD166, and CD271, among others. These cells also show multilineage differentiation ability and immunomodulatory effects on pre-stimulated lymphocytes. Thorough characterization of these cells showed that a PD-MSCPL resembles an umbilical cord (UC) MSC and differs from a PSC in surface marker and extracellular matrix proteins and integrin expression. Moreover, the OCT-4 promoter is re-methylated with mesenchymal differentiation comparable with the methylation levels of UC-MSCs and fibroblasts. Lastly, the use of PL-supplemented medium generates significantly more MSCs than the use of fetal bovine serum. Conclusions: This protocol can be used to generate a large amount of PD-MSCs with low cost and is compatible with clinical therapies.
- 15 July 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 410 (4) , 816-822
Modulation of chromatin modifying factors’ gene expression in embryonic and induced pluripotent stem cells
- 15 July 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 410 (4) , 816-822
Modulation of chromatin modifying factors’ gene expression in embryonic and induced pluripotent stem cells
- 1 July 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 410 (2) , 252-257
Induced pluripotent stem cells’ self-renewal and pluripotency is maintained by a bovine granulosa cell line-conditioned medium
- 1 July 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 410 (2) , 252-257
Induced pluripotent stem cells’ self-renewal and pluripotency is maintained by a bovine granulosa cell line-conditioned medium